Status:
Topic prioritisation
Technology type:
Medicine
Decision:
Not selected
Reason for decision:
Not eligible for Health Technology Evaluation guidance
Rationale:
Dear stakeholders, For information, the company have advised that they are no longer pursuing a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme.
ID number:
11961

Project Team

Project lead
Danielle Lees

Email enquiries

If you have any queries please email topic.selection@nice.org.uk


For further information on how we select topics for development, please see our page about topic prioritisation